STUDY QUESTION: Is maternal use of mild analgesics in pregnancy associated with anogenital distance (AGD)-the distance from the anus to the genitals-in the offspring?
associated with AGD as this was unknown to the women at time of reply to the questionnaire thereby underestimating the association. Confounding by indication may also explain our findings, as the condition for which the analgesic was taken may be associated with a reduction in AGD, rather than the use of the analgesic medication. This is the first study to report such an association in humans and further studies are needed to confirm our findings.
WIDER IMPLICATIONS OF THE FINDINGS:
A negative association was observed between exposure to analgesics during pregnancy and AGD in boys, suggesting disruption of androgen action. The health implications of a shorter AGD are still uncertain, but in crosssectional studies among adult men a shorter AGD is associated with poorer semen quality and lower testosterone. As 41% of the women used these painkillers the finding are of public health importance and pregnant women should be advised about the potentially harmful effects of painkiller use.
Introduction
Paracetamol (acetaminophen) and nonsteroidal anti-inflammatory drugs (NSAIDs), e.g. ibuprofen and acetyl salicylic acid (aspirin) are among the most widely used analgesics in Western countries. More than 50% of pregnant women use mild analgesics during pregnancy (Werler et al., 2005; McKenna and McIntyre, 2006; Kristensen et al., 2011) . These pharmaceutical agents are known to cross the placenta (Levy et al., 1975; Weigand et al., 1984) and have recently joined the growing list of chemicals with potential endocrine disrupting abilities (Kristensen et al., 2012) .
Testicular dysgenesis syndrome (TDS), which includes reproductive disorders such as cryptorchidism, hypospadias, poor semen quality and testicular cancer, is hypothesized to be of fetal origin and due to disturbance of testicular development (Skakkebaek et al., 2001; Welsh et al., 2008) . These conditions are interlinked as they share common risk factors and some are, in turn, risk factors for each other (Skakkebaek et al., 2001) . Anogenital distance (AGD)-the distance from the anus to the genitals-has long been used in rodent studies for sex determination of pups and to evaluate reproductive toxicity (Gallavan et al., 1999) . Males have a longer AGD than females and a reduced male AGD may therefore indicate insufficient androgen action during early stages of reproductive organ development (Dean and Sharpe, 2013) . On the other hand a longer female AGD may suggest excess androgen exposure during early stages of reproductive development (Welsh et al., 2008) . A shorter AGD has in cross-sectional studies been associated with poor semen quality in adult men (Eisenberg et al., 2011; Mendiola et al., 2011) , and hypospadias and cryptorchidism (Hsieh et al., 2012; Thankamony et al., 2014) in newborns. AGD is, therefore, suggested to be part of the TDS (Juul et al., 2014) .
In rats prenatal exposure to paracetamol was demonstrated to decrease AGD in male offspring (Kristensen et al., 2011) . Two Danish and one Dutch study reported that exposure to paracetamol alone or in combination with NSAIDs during the first and second trimester was associated with an increased risk of cryptorchidism (Jensen et al., 2010; Kristensen et al., 2011; Snijder et al., 2012) . These findings are consistent with those of an earlier American study showing an association between the use of analgesics during pregnancy and an increased risk of cryptorchidism (Berkowitz and Lapinski, 1996) .
To our knowledge no human studies has investigated the association between maternal use of mild analgesics in pregnancy and AGD in the offspring. We therefore studied the association between maternal exposure to analgesics and AGD in the offspring at 3 months of age among 1027 mother-child pairs in the Odense Child Cohort.
Materials and Methods

Study population
All pregnant women residing between January 2010 and December 2012 in the Municipality of Odense in the Region of Southern Denmark were invited to participate in the Odense Child Cohort. Pregnant women were recruited at a voluntary information meeting introducing the routine ultrasound examination at Odense University Hospital or at their first antenatal visit to their midwife at gestational age (GA) 8-16 weeks. We approached 6707 pregnant women; 4017 consented to receive oral and written information about the study, and 2874 (42.9%) enrolled in the cohort, signing an informed consent form (Fig. 1 ). Participants were better educated, smoked less and were more often of Danish origin than non-participants (Kyhl et al., 2015) . As of November 2014, 2448 singleton children were active members of the cohort (Fig. 1) . Information about maternal prepregnancy BMI, smoking, GA (days) at birth and birth size was obtained from hospital birth records.
Exposure assessment
All pregnant women were asked to complete two questionnaires (Q) during pregnancy. Q1 was sent out after recruitment (GA 10-27 weeks) and contained questions about general health, lifestyle, education, ethnicity, fertility treatment and intake of both prescribed and over-thecounter medicine during pregnancy. The women were asked 'Did you use any kind of medication during pregnancy (prescribed or over-thecounter)?', and if so to state the name, dose and gestational week of use. The content of Q1 changed during the recruitment period (first version of Q1 used from January 2010 to March 2011). The first version of Q1 did not contain any questions about medicine intake during pregnancy and women (N = 362) who responded to this version were excluded (Fig. 1) .
Q2 was sent out at GA 28 weeks. The women were asked if they had had any illnesses, e.g. headache, migraine, cold or muscle pain during pregnancy, and whether they took any medication. Furthermore, they were asked to fill out a table for use of over-the-counter medication and a table for prescription medications. They were asked to fill in the drug name, dose, duration and period of gestational use (in the following categories: GA 4-9, 10-14, 15-19, 20-24 and 25-29 weeks) .
We defined use of paracetamol and other mild analgesics as selfreported use of these drugs at least once during the first 28 weeks at pregnancy, irrespective of dose and length of uses. We manually reviewed all the questionnaires and coded painkiller intake. For paracetamol we were able to divide into first trimester, second trimester or both trimesters use for most women. However, 9% of the women did not specify the time period in which they had used paracetamol. These were categorized as 'unspecified time'. The number of women who reported use of ibuprofen and acetyl salicylic acid was too small to categorize into trimester use and these women were categorized as use/no use of 'other analgesics'. We combined the information on intake of paracetamol and other analgesics into seven mutually exclusive groups: (i) No use of analgesics, (ii) use of paracetamol in the first trimester, (iii) use of paracetamol in the second trimester, (iv) use of paracetamol in both first and second trimester, (v) use of paracetamol at an unknown time, (vi) use of other analgesics and (vii) use of both paracetamol and other analgesics.
AGD measurements
Three months after the expected date of birth (median age 3.5 months, range 2.1-6.8 months) mothers were invited for a clinical examination of their children including measurements of length, weight and AGD. A preterm baby, born in week 36 for example, was therefore examined at 4 months of age thereby taking into account differences in GA.
AGD was measured in accordance with the standardized measurement methods developed for The Infant Development and the Environment Study (TIDES), described elsewhere (Sathyanarayana et al., 2015) . A skilled TIDES examiner trained examiners in the Odense Child Cohort on these methods.
Two measurements were made on all children; a 'short' and a 'long' AGD. In boys, the short AGD was measured from the center of the anus to the posterior base of scrotum (AGD AS ) and a long AGD was measured from the center of the anus to the anterior base of the penis (AGD AP ) using a Vernier caliper (Fiberglass Dial Caliper, Spi 31-415-3). Penile width was measured at the base of the penis with the same Vernier caliper. Correspondingly, in girls a short AGD was measured from the center of the anus to the posterior fourchette (AGD AF ) and a long AGD from the center of anus to the top of the clitoris (AGD AC ). The genital measures were repeated three times for each child and an arithmetic mean was calculated. It is technically more difficult to measure AGD in females, as the landmarks are less obvious. The technicians therefore needed further guidance before being able to measure AGD in girls accurately, and as the variance between the first 46 measurements was high, they were excluded. We observed no such problems with AGD measurements in boys. The coefficient of variation for the triplicate AGD measurements was on average 3-4% for girls and 2-3% for boys. AGD measurements among boys were significantly shorter in 2013 compared to 2010 (AGD AS : −0.2 mm per months; CI 95%: −0.2; −0.1). This drifting over time has been seen in other studies and is thought to be a training effect, as seen elsewhere (Mendiola et al., 2014) . We did not see this phenomenon in girls' AGD (AGD AC : 0.0 mm per months; CI 95%: −0.1; 0.1).
Approximately 1700 women answered Q1 or Q2, while 1332 mothers answered both questionnaires ( Fig. 1) . To minimize the risk of misclassification we limited our analysis to mothers who had answered questions about medicine intake in both questionnaires and children who had their AGD measured at 3 months of age. In total 470 girls and 557 boys were eligible for the analysis (Fig. 1 ). 
Ethical approval
Statistical analysis
We calculated the mean of AGDs and penile width in the seven exposure groups (according to use of analgesics). Differences in the mean of AGD and penile width between the exposure groups were tested with a one-way ANOVA. Differences in the characteristics of the pregnant women in relation to use of paracetamol and other analgesics were tested by a chi-square test for categorical variables, ANOVA for normally distributed continuous variables and KruskalWallis test for GA. Differences in AGDs and penile width in relation to population characteristics were tested with ANOVA in order to examine possible confounders.
Multiple linear regressions were carried out to analyze associations between use of analgesics in pregnancy and AGD and penile width at 3 months of age adjusting for potential confounders. AGD measurements and penile width were left untransformed due to acceptable normal distributions of the residuals. Since AGD measurements vary with age and weight of the child, we constructed a measure of 'postconceptional age' which was defined as the sum of GA at birth (in days) and chronological age at the AGD measurements (in days). Ageand sex-specific Z-scores for weight were calculated on the basis of all 2041 singletons who participated in the 3 months examination in the Odense Child Cohort, taking their post-conceptional age into account.
Generally, few human studies (reviewed in Jensen et al. 2016) have assessed AGD and there is no consistency over which factors should be considered as confounders, apart from weight. We therefore tested all potential confounders; parity (primiparous/multiparous), preterm birth (<37 weeks of gestation), maternal smoking during pregnancy (yes/no), fertility treatment (any fertility treatment to conceive current pregnancy (yes/no)), pre-pregnancy BMI (<18.5, 18.5-25, 25+ kg/m 2 ), maternal ethnicity (mother or her parents born in Western countries (yes/no), maternal education level ((primary (minimum ninth grade), secondary (minimum high school or equivalent) and tertiary (minimum bachelor degree or equivalent)). None of these covariates changed the estimated beta-coefficient >5% and were therefore excluded from the final models. Our final regression models of the association between use of analgesics and AGDs were adjusted for post-conceptional age and Z-score for weight at 3 months. For boys we included time of examination (0-35 months) as an integer variable in the model, to adjust for the change in AGD AS we saw over time.
We performed several sensitivity analyses. We stratified on stressful life-events and conditions that could trigger the use of analgesics: influenza, cold, muscle-joint pain, headache or migraine. To determine the consistency of our results we performed secondary analyses including all women who had answered Q2 around GA 28 weeks and had AGD measured at 3 months of age.
A value of P < 0.05 was considered to be significant. All data analyses were performed using STATA version 14 (STATA, TX, USA).
Results
The mean age of the women at birth was 30.9 years, 57% of the women were pregnant with their first child, and mean birthweight was 3453 g for girls and 3572 g for boys. A total of 2% (N = 25) had a birthweight <2500 g and 4% (N = 45) were born preterm (before gestational week 37), 11% had received fertility treatment for the current pregnancy, 2.5% smoked during pregnancy and 4.5% of the women were of non-Western origin. Fewer women included in this study smoked (3% versus 6% P < 0.01) compared to those who did not fill out both Q1 and Q2. Among women who did not fill out both Q1 and Q2, 253 boys and 174 girls had AGD measured. These AGD measurements did not differ from AGD among the included children. Birthweight, sex, parity and age did not differ between women-childpairs included (N = 1027) and those not included (N = 1394).
Use of paracetamol at any time during pregnancy was reported by 39.9% of the women, while 4.4% reported use of other analgesics (ibuprofen and/or acetyl salicylic acid). No trend in use across study period was detected. In total 3.3% stated use of both paracetamol and other analgesics in pregnancy (Table I) . AGD AS , AGD AP and penile width were correlated (AGD AS −AGD AP : r = 0.61; penile width-AGD AS : r = 0.16 and AGD AP : r = 0.18). Mean AGDs and penile width for exposed and unexposed boys are shown in Table I . We found no association between exposure only to paracetamol and AGD, whereas exposure to both paracetamol and other analgesics was associated with a shorter AGD AS compared tp unexposed (mean: 32.3 mm versus 36.2 mm, P = 0.03). The two AGD measurements in girls were also correlated (r = 0.55). No associations were found between maternal use of mild analgesics and AGD in female offspring (Supplementary Table SI) .
Women who used paracetamol or other analgesics during pregnancy were older, more often multiparous and of Western origin, had a higher BMI, smoked less and were more often exposed to stressful events compared to women who reported no use (Table II) . AGD and penile width differed only with ethnicity of the mother (Western/ none-Western origin) and birthweight of the child (data not shown).
Maternal use of paracetamol only was not significantly associated with AGD in boys after adjustment but a tendency towards a reduced AGD AS was seen (Table III) among exposed boys, especially boys exposed in second trimester (AGD AS −0.8; 95% CI: −2.1; 0.5). Simultaneous maternal use of both paracetamol and other analgesics (N = 20) was associated with a significantly shorter AGD AS in boys compared with non-exposed boys (−4.1 mm; 95% CI: −6.4; −1.7). We found no association between exposure to mild analgesics and AGD AP (Fig. 2) . Women who reported paracetamol use during pregnancy but did not specify when, gave birth to boys with a smaller penile width than the non-exposed boys (−0.7 mm, 95% CI: −1.1;−0.3) (see Table III ). No consistent pattern was found between prenatal exposure to mild analgesics in any category and AGD in girls (Supplementary  Table SII) .
Stratification by stressful life-events in pregnancy or indication for use (headache, migraine, cold, flu, muscle pain) did not change the associations. Most women had taken analgesic for relief of influenza or cold symptoms, muscle or joint pain, headache or migraine and among these groups overall the same tendencies were found although sample sizes were smaller (Supplementary Table SIII) . Among all women who answered Q2 (boys, N = 729; girls, N = 581) the association between use of analgesics and AGD was attenuated (AGD AS −3.2 mm, 95% CI: −4.2; −0.5), but still significant.
Discussion
This is the first human study to report an association between maternal use of mild analgesics during pregnancy and AGD in male offspring. Twenty boys prenatally exposed to both paracetamol and NSAID had a significantly 4.1 mm shorter AGD than unexposed. In addition, 41% of the pregnant women used paracetamol and use was associated with a shorter AGD in the male offspring (especially second trimester use) although not statistically significant. No adverse effect of maternal use of mild analgesics during pregnancy and AGD in girls was observed. A shorter AGD suggests an anti-androgenic effect during a critical developmental window in male reproductive development (Welsh et al., 2008) . A 4.1 mm shorter AGD corresponds to a 11% decrease and may be of clinical importance as it has been associated with genital malformations such as cryptorchidism and hypospadias and semen quality and testosterone in adult life (Skakkebaek et al., 2001; Eisenberg et al., 2011; Mendiola et al., 2011; Hsieh et al., 2012; Juul et al., 2014; Thankamony et al., 2014) . A smaller penile width was only found among women who did not specify the timing of painkiller use and not among other women, therefore we believe this may be a chance finding.
Three previous studies have reported a positive association between maternal use of analgesics in pregnancy and cryptorchidism in the offspring (Jensen et al., 2010; Kristensen et al., 2011; Snijder et al., 2012) . Thus, previous human studies suggest that exposure to analgesics in utero may be associated with cryptorchidism in humans but no studies have to our knowledge assessed the effect of use of mild analgesics on AGD in the offspring.
We cannot offer any explanation as to why combined use of paracetamol and NSAID had a larger impact on AGD apart from the fact that these women were exposed to more than one drug and therefore probably also higher doses but it may also be a chance finding. AGD is determined by androgen action in the male programming window in rats (Welsh et al., 2008) . Paracetamol and acetyl salicylic acid exposure in utero reduced AGD in male rats (Kristensen et al., 2011) and the production of testosterone in fetal rat testis (Kristensen et al., 2012) . Testosterone level in the fetal rat testis was reduced and a reduced expression of Cyp11a1 and Cyp17a1, two key enzymes in steroidogenesis (van den Driesche et al., 2015) was reported among paracetamol exposed. In line with the rodent data, a recent xenograft study, in which human fetal testes from gestational week 14-20 were implanted into a immunocompromised mouse model, found that 7-day exposure to therapeutic doses of paracetamol reduced testosterone synthesis by 45%, whereas exposure for just one day did not affect testosterone production (van den Driesche et al., 2015) . A key transcription factor for male reproductive development, insulin-like factor 3 (INSL3) dose-dependently decreased by exposure to paracetamol at levels comparable to and below therapeutic doses (Mazaud-Guittot et al., 2013) . INSL3, which like testosterone is produced by the Leydig cells, plays a role in the transabdominal phase of testicular descent during the second trimester (Bay et al., 2011; Foresta et al., 2008; Ivell and Anand-Ivell, 2009 ). Hence, a reduction in INSL3 production may contribute to the mechanisms by which analgesics increase the risk of congenital cryptorchidism (Mazaud-Guittot et al., 2013).
The analgesic and anti-inflammatory effect of NSAIDs and paracetamol is through inhibition of prostaglandin synthesis (Graham et al., 2013) . The relationship between the prostaglandin system and steroidogenesis is only poorly understood but prostaglandin D2 is expressed in a male-specific manner during testicular organogenesis in mice and can up-regulate SOX9, is a central regulator of male sex determination (Adams and McLaren, 2002; Malki et al., 2005; Wilhelm et al., 2007) . Supporting this line of evidence, mice with a knockout of the lipocalin-type prostaglandin D2 synthase gene (PTGDS) have unilateral cryptorchidism (Philibert et al., 2013) . However, investigations of the role of PTGDS in boys with cryptorchidism, based on the sequencing of the PTGDS gene, discovered no aberration of the gene in humans (Philibert et al., 2013) . In our study, we found stronger associations between maternal use of analgesics and AGD AS than AGD AP . This may be related to technical issues, as measuring AGD AP is more difficult than AGD AS . The landmark where the scrotal skin meets the perineum is easy to visualize (landmark for AGD AS ), while the anterior base of the penis (landmark for AGD AP ) is more variable due to subcutaneous fat deposits. In addition, AGD AS better reflects the anatomical line of the caudo-cranial fusion of the urogenital sinus during early fetal life by testosterone and dihydrotestosterone action. We found no association between maternal use of analgesics and AGD in girls. Little is known about AGD in females and its potential relation to the reproductive system (Mendiola et al., 2012) . AGD in newborn girls has previously been negatively associated with prenatal exposure to endocrine disrupters (e.g. phthalate exposure)
. Figure 2 Adjusted* multiple linear regression analysis (β coefficient and 95% CI) of association between maternal use of mild analgesic during pregnancy and AGD and penile width at 3 months of age in 557 male offspring. NSAID: nonsteroidal anti-inflammatory. (Huang et al., 2009 ) and in women with normal reproductive function an association between AGD and follicular number was found (Mendiola et al., 2012) . However, it is technically more difficult to measure AGD in females as the landmarks are less obvious Sathyanarayana et al., 2015) , which was why we had to exclude the first 46 measurements due to high variability between examiners. Our study has several strengths; it was a large population-based mother-child cohort and AGD was measured three times by trained technicians who were blinded to questionnaire information including medicine use in pregnancy. In the Odense Child Cohort, coefficients of variability for AGD were small: on average 2-4%. However, only 42% of the eligible women participated in the Odense Child Cohort, and of those women only 42% completed both questionnaires and had AGD measurements at 3 months of age in their children. Selection bias can therefore not be ruled out, however, AGD measurements did not differ between included and excluded children and the women were unaware of AGD of their children when they responded to questions about the medicine intake, thereby making differential selection unlikely.
Use of mild analgesics was self-reported up to 2 months after intake which could have caused misclassification of exposure but is probably not associated with AGD as this was unknown to the women at time of reply to the questionnaire, thereby underestimating the association. In addition, only 27 boys and 18 girls were exposed to NSAIDs and most of them were also exposed to paracetamol. This makes it impossible to distinguish between exposures to NSAIDs alone and a potential mixture effect. In addition, AGD measurements among boys drifted over time probably due to training (Mendiola et al., 2014) . We adjusted for this drifting. Confounding by indication may also explain our findings, as the condition for which the analgesic was taken may be associated with a reduction in AGD, rather than the use of the analgesic medication. Most women had taken analgesic for relief for influenza or common cold symptoms, muscle or joint pain, headache or migraine and among these groups the same associations between use of analgesic and AGD were found. The women who reported use of more than one painkiller may have been more ill and this may explain our findings of the strongest adverse effect on AGD of combined use.
Our study confirmed the previously reported high frequency of use of mild analgesics among pregnant women; 40% reported use of paracetamol and 4% used other analgesics. This is in accordance with two previous Danish studies; respectively 47% and 56% reported use of paracetamol, and 5% and 7% reported use of ibuprofen and acetyl salicylic acid (Jensen et al., 2010; Kristensen et al., 2011) . In France and USA, respectively, 76.1% and 89.9% of women, reported using analgesics during pregnancy (Werler et al., 2005; Philippat et al., 2011) . We cannot offer an explanation as to why the use in pregnant women in Denmark is lower than elsewhere but generally Danish women are advised to avoid use of medicine during pregnancy. Still the frequency of use is high and is of concern as mild analgesics appears to have antiandrogenic effects in the male fetus, i.e. associated with a shorter AGD which, in turn, is associated with genital malformations such as cryptorchidism and hypospadias and semen quality in adult life (Skakkebaek et al., 2001; Eisenberg et al., 2011; Mendiola et al., 2011; Hsieh et al., 2012; Juul et al., 2014; Thankamony et al., 2014) .
In conclusion, we found an association between maternal use of mild analgesics and shorter AGD in sons although this was only statistically significant among 20 boys exposed to both NSAID and paracetamol, which suggests a reduction of prenatal androgen action. This is the first study to report such an association in humans and further studies are needed to confirm our findings. However, since the use of mild analgesics is common in pregnant women (41% of women in our study used paracetamol), healthcare professionals as well as pregnant women should be advised about the potential harmful effects in the offspring.
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